Where medicine meets the microbiome.

AI + Gut = Hope: Let's rewrite cancer's future.

The microbiome modulates immune responses, influences cancer therapy efficacy, and offers novel targets for developing treatments, representing a pivotal frontier in oncology research.

Using advances in AI, we decode microbiomes to pioneer cancer therapies.

Unlocking precision medicine.

A vast genetic universe of bacteria, yeasts, viruses and parasites that live inside us, influencing every aspect of our health, even the way we think and feel.

Read more

Decoding microbiomes for advanced therapeutic strategies.

Developing new therapies.

Breakthrough technologies such as gene sequencing have revealed the vast complexity of microbial life in and on the human body. We're investigating how the microbiome may be tied not only to cancer but also to obesity, heart disease, mental health, vaccine efficacy and responses to cancer treatments such as chemotherapy. This work has important implications for prevention and for developing new therapies that harness immune defences to fight cancer and disease.

Read more

Initial research

01

Discovery and preclinical research

Identifying biological targets, understanding disease mechanisms, and conducting laboratory experiments.

Human testing

02

Clinical trials

Testing safety and efficacy in humans through phased studies.

Approval and release

03

Regulatory approval and market access

Gaining official authorisation and making the therapy available to patients.

Research

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

2023

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

2023

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

2023

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

2023

Join the team

Want to innovate at the intersection of healthcare and technology?

Work on one of the world's most important problems.